Effect of Serial Clinical Observation Complemented by Point-of-Care Blood Culture Volume Verification on Antibiotic

Tomasz Wawrzoniak1, Justyna Romańska1

  • 1Medical University of Warsaw, Warsaw, Poland.

Global Pediatric Health
|January 25, 2024
PubMed

Insights

A new strategy using clinical observation and blood culture checks significantly reduced antibiotic use in newborns at risk for early-onset sepsis. This approach lowered antibiotic exposure from 4.1% to 0.6% in at-risk infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Clinical Practice Guidelines

Background:

  • Early-onset sepsis poses a significant risk to term and near-term newborns.
  • Overuse of antibiotics in neonates can lead to adverse outcomes, including antimicrobial resistance.
  • Accurate assessment of blood culture volume is crucial for reliable sepsis diagnosis.

Purpose of the Study:

  • To evaluate the impact of a serial clinical observation strategy combined with point-of-care blood culture volume verification.
  • To assess the effect of this strategy on antibiotic utilization in newborns at risk for early-onset sepsis.

Main Methods:

  • A before-and-after study design was employed.
  • Infants born at or after 35 0/7 weeks' gestation were included.
  • The strategy involved serial clinical observation and point-of-care verification of blood culture volume.

Main Results:

  • Antibiotic therapy initiation within the first 3 days of life decreased significantly post-intervention (0.6% vs. 4.1%).
  • The relative risk of antibiotic exposure was substantially reduced (RR: 0.15; 95% CI: 0.08-0.28).
  • The observed reduction in antibiotic use was statistically significant (P < .001).

Conclusions:

  • Serial clinical observation and blood culture volume verification can effectively reduce unnecessary antibiotic use in newborns.
  • This strategy offers a promising approach to managing neonatal sepsis risk while minimizing antibiotic exposure.
  • Optimizing sepsis management protocols can improve neonatal outcomes and combat antimicrobial resistance.